Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Development, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matrices.

Shum YY, Huang N, Walter G, Black A, Sekerke C, Chang T, Whitfield LR.

Ther Drug Monit. 1998 Feb;20(1):41-9.

PMID:
9485553
2.
3.

Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.

Woolf TF, Black A, Shum YY, McNally W, Lee H, Chang T.

Drug Metab Dispos. 1993 Nov-Dec;21(6):1112-8.

PMID:
7905392
4.

Biodehalogenation and metabolism of 125[I]-4-iodobiphenyl.

Sinsheimer JE, Shum YY.

J Pharm Sci. 1981 May;70(5):546-9.

PMID:
7241361
5.

Determination of iodide in metabolic studies of 125I-labeled compounds.

Shum YY, Sinsheimer JE.

J Pharm Sci. 1979 Feb;68(2):258-9.

PMID:
370363
6.

Mechanisms for the biodehalogenation of iodocompounds.

Sinsheimer JE, Wang T, Röder S, Shum YY.

Biochem Biophys Res Commun. 1978 Jul 14;83(1):281-6. No abstract available.

7.

Unexpected formation of thioacridone and its spectral properties.

DeLeenheer A, Shum YY, Sinsheimer JE, Burckhalter JH.

J Pharm Sci. 1971 Aug;60(8):1238-9. No abstract available.

PMID:
5127098

Supplemental Content

Support Center